Alcohol labelling – right to know
EASL together with Eurocare, UEG and The Standing Committee of European Doctors (CPME) call attention on the need for detailed, government monitored alcohol labelling to become a Europe-wide regulation. Consumers have a…
EASL-CLIF Consortium founding member receives special award
Prof. Richard Moreau has received a special award from the French Association for the Study of the Liver (AFEF). The “Prix spécial francophone pour l’Etude de l’Hypertension Portale” was awarded to Prof.…
New EASL member zone now online
We are happy to announce the launch of the new EASL member zone designed to improve your experience as an EASL member. You will now find it easier to: Create your profile…
The ILC 2020 website is live!
Visit the new ILC 2020 website to find out the latest information about The International Liver Congress™ 2020. At ILC 2020, EASL is turning its attention to health in daily life and…
Obesity epidemic results in Non-Alcoholic Fatty Liver Disease (NAFLD) becoming the most common cause of liver disease in Europe.
World´s leading experts gather in Seville to discuss the fastest growing health epidemic in Europe now affecting 1 in 4 people. 26 September 2019 – Seville, Spain The Non-Alcoholic Fatty Liver Disease…
Why fatty liver disease could be the next public health crisis
Is non-alcoholic fatty liver disease the next public health crisis? After singer George Michael passed away in 2016, the coroner's report listed fatty liver disease as one of the causes of death.…
ELPA announces ELPA Pre-Summit on NAFLD
"Save the date! ELPA announces ELPA Pre-Summit on NAFLD – information for and from patients, patient experiences and views on NAFLD, as a back to back event to EASL NAFLD Summit on…